Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for tourniquet-related hemodynamic and pulmonary effects during total knee arthroplasty
ChiCTR-TRC-11001714Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in Cardiovascular collapse and not applicable; "lung injury" is not a specific disease (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoints: Heart rate, Mean arterial pressure and 4 more. Started Jul 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular collapsenot applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on ChiCTR-TRC-11001714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001714.